OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CIANYSE$5.2664

CITIZENS, INC.

InsuranceRules + LLM

CITIZENS, INC. has a liquidity position that is currently low, as indicated by its cash and equivalents of $18.52 million and a negative free cash flow of $649,000 in Q1 2026. The company's debt-to-equity ratio is 0.0, suggesting it is not leveraging debt to finance its operations. However, the company's return on equity of 0.95% and return on assets of 0.13% are below the industry median for insurance companies, indicating that it is not generating strong returns relative to its equity and asset base. The company's profitability is modest, with a net income of $2.27 million on revenue of $59.72 million in Q1 2026. This results in a net margin of 3.8%, which is below the industry median for insurance companies. The company's operating cash flow is negative at $323,000, which may indicate challenges in converting operations into cash. CITIZENS, INC. operates primarily in the domestic insurance segment, with a focus on niche markets such as final expense insurance. The company's revenue is concentrated in this segment, with no significant international operations reported in the latest financial data. The company has a coinsurance agreement with RGA Reinsurance Company to provide more capacity for growth in its Domestic Insurance segment. The company's growth trajectory is positive, with direct first-year premiums in the Domestic Insurance segment increasing by 23% in 2025 compared to 2024. This growth is attributed to increased market demand for final expense products. However, the company's operating cash flow and free cash flow are negative, which may limit its ability to reinvest in growth opportunities. The company faces medium dilution risk, as indicated by the risk assessment, with source documents mentioning dilution or offering risk. The company's liquidity risk is also low, but the negative free cash flow and operating cash flow suggest potential challenges in maintaining liquidity. The company has evaluated subsequent events through the date of the report and determined that no other significant subsequent events need to be recognized or disclosed. Recent events include the company's focus on elevating the customer experience through digital tools, as policyholders expect simpler buying experiences that include faster underwriting and digital experiences. The company has also entered into a coinsurance agreement with RGA Reinsurance Company to provide more capacity for growth in its Domestic Insurance segment.

30-day price · CIA-0.65 (-11.6%)
Low$4.72High$5.81Close$4.94As of22 May, 00:00 UTC
Profile
CompanyCITIZENS, INC.
ExchangeNYSE
TickerCIA
CIK0000024090
SICLife Insurance
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryInsurance
AI analysis

Business. CITIZENS, INC. specializes in offering primarily individual whole life insurance, endowment products, and final expense insurance in niche markets where it believes it can optimize its competitive position.

Classification. CITIZENS, INC. is classified under the Financials sector, specifically in the Insurance industry, with a confidence level of 0.98 based on rule-based classification.

CITIZENS, INC. has a liquidity position that is currently low, as indicated by its cash and equivalents of $18.52 million and a negative free cash flow of $649,000 in Q1 2026. The company's debt-to-equity ratio is 0.0, suggesting it is not leveraging debt to finance its operations. However, the company's return on equity of 0.95% and return on assets of 0.13% are below the industry median for insurance companies, indicating that it is not generating strong returns relative to its equity and asset base. The company's profitability is modest, with a net income of $2.27 million on revenue of $59.72 million in Q1 2026. This results in a net margin of 3.8%, which is below the industry median for insurance companies. The company's operating cash flow is negative at $323,000, which may indicate challenges in converting operations into cash. CITIZENS, INC. operates primarily in the domestic insurance segment, with a focus on niche markets such as final expense insurance. The company's revenue is concentrated in this segment, with no significant international operations reported in the latest financial data. The company has a coinsurance agreement with RGA Reinsurance Company to provide more capacity for growth in its Domestic Insurance segment. The company's growth trajectory is positive, with direct first-year premiums in the Domestic Insurance segment increasing by 23% in 2025 compared to 2024. This growth is attributed to increased market demand for final expense products. However, the company's operating cash flow and free cash flow are negative, which may limit its ability to reinvest in growth opportunities. The company faces medium dilution risk, as indicated by the risk assessment, with source documents mentioning dilution or offering risk. The company's liquidity risk is also low, but the negative free cash flow and operating cash flow suggest potential challenges in maintaining liquidity. The company has evaluated subsequent events through the date of the report and determined that no other significant subsequent events need to be recognized or disclosed. Recent events include the company's focus on elevating the customer experience through digital tools, as policyholders expect simpler buying experiences that include faster underwriting and digital experiences. The company has also entered into a coinsurance agreement with RGA Reinsurance Company to provide more capacity for growth in its Domestic Insurance segment.
Key takeaways
  • CITIZENS, INC. has a low liquidity position with negative free cash flow and operating cash flow.
  • The company's return on equity and return on assets are below the industry median for insurance companies.
  • The company's growth is driven by increased market demand for final expense products, with a 23% increase in direct first-year premiums in 2025.
  • The company faces medium dilution risk, as indicated by the risk assessment.
  • The company is focusing on digital tools to enhance the customer experience and meet policyholder expectations.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodQ1 2026
CurrencyUSD
Revenue$59.7M
Gross profit
Operating income
Net income$2.3M
R&D
SG&A
D&A
SBC
Operating cash flow-$323.0k
CapEx$326.0k
Free cash flow-$649.0k
Total assets$1.74B
Total liabilities$1.50B
Total equity$238.7M
Cash & equivalents$18.5M
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$255.6M$14.6M$17.5M
FY2025$62.8M$2.4M
FY2025$65.1M$6.5M
FY2025$55.7M-$1.6M
FY2024$245.0M$14.9M$31.3M
PeriodGross %Op %Net %FCF %
FY2025
FY2025
FY2025
FY2025
FY2024
PeriodAssetsEquityCashDebt
FY2025$1.75B$235.0M$23.0M
FY2025
FY2025
FY2025
FY2024$1.69B$210.4M$29.3M
PeriodOCFCapExFCFSBC
FY2025$18.0M$447.0k$17.5M
FY2025
FY2025
FY2025
FY2024$31.9M$663.0k$31.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q1 2026$59.7M$2.3M-$649.0k
Q1 2026
Q3 2025$183.5M$7.3M$8.5M
Q2 2025$120.7M$4.8M$3.9M
PeriodGross %Op %Net %FCF %
Q1 2026
Q1 2026
Q3 2025
Q2 2025
PeriodAssetsEquityCashDebt
Q1 2026$1.74B$238.7M$18.5M
Q1 2026$1.75B$235.0M$23.0M
Q3 2025$1.74B$225.6M$23.1M
Q2 2025$1.71B$229.0M$22.7M
PeriodOCFCapExFCFSBC
Q1 2026-$323.0k$326.0k-$649.0k
Q1 2026
Q3 2025$8.9M$343.0k$8.5M
Q2 2025$4.2M$283.0k$3.9M
Valuation
Market price$5.26
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$238.7M
Net cash$18.5M
Current ratio
Debt/Equity0.0
ROA0.1%
ROE0.9%
Cash conversion-14.0%
CapEx/Revenue0.5%
SBC/Revenue
Asset intensity0.0
Dilution ratio
Risk assessment
Dilution riskMedium
Liquidity riskLow
  • Source documents mention dilution or offering risk.
Industry benchmarks
Activity: Multiline Insurance & Brokers · cohort 6 companies
MetricCIAActivity
Op margin0.7% medp25 -1.3% · p75 1.2%
Net margin3.8%-1.0% medp25 -166.7% · p75 3.8%above median
Gross margin23.9% medp25 22.9% · p75 34.2%
R&D / revenue164.8% medp25 164.8% · p75 164.8%
CapEx / revenue0.5%1.8% medp25 0.8% · p75 2.6%bottom quartile
Debt / equity0.0%14.5% medp25 -291.3% · p75 44.9%below median
Recent coverage
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 17:31 UTC#cdcb66cd
Market quoteclose USD 5.25 · shares 0.05B diluted
no public URL
2026-05-04 17:31 UTC#27bca4b4
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 15:39 UTCJob: 323ff888